Oragenics OGEN
Oragenics: proxy statement
- Form
- DEF 14A
- Filed
- Importance
- Routine
- Accession
- 0001493152-26-024602
Not explained yet; the original is on EDGAR.
Proxy statement
Similar companies
Same SIC code (2834) and public float under $300M, nearest public float first, as each company reports it on its annual report cover.
- Inhibitor Therapeutics INTI public float $3M, Jun 30, 2025
- PTC Therapeutics PTCT public float $3M, Jun 30, 2025
- Integrated Biopharma INBP public float $3M, Dec 31, 2025
- Enveric Biosciences ENVB public float $4M, Jun 30, 2025
- Polomar Health Services PMHS public float $4M, Jun 30, 2025